A new analysis of the CASTLE-AF trial has found that catheter ablation for AFib remains effective in a much larger group of heart failure patients, cementing evidence first presented in early 2018.
SymphonyAI is focused on business-to-business artificial intelligence solutions, serving industries such as healthcare, manufacturing, retail, oil and media.
Montefiore Medical Center has been running its pretreatment nuclear medicine clinic for 14 years, and its had an overwhelming impact on patients, according to a new study published in Current Problems in Diagnostic Radiology.
A host of prescription drugs—including warfarin and other CV medications—may have potential drug interactions with the THC and cannabidiol in marijuana, according to an article published in the Canadian Medical Association Journal.
SymphonyAI Group, a private group of companies specializing in AI, announced Wednesday, March 4, that it has acquired TeraRecon. No financial details have been shared at this time.
The European Society of Cardiology has canceled its annual Acute Cardiovascular Care conference slated for March 7-9 in Athens, Greece. Coronavirus was named as the reason for the change of plans.
ACR and its National Radiology Data Registry team said these additions are aimed at encouraging appropriate imaging follow-up, proper documentation of the final report and use of low-dose CT.
Augmented reality (AR) technology could play a pivotal role in the interventional radiology (IR) suite of the future, according to a new study published in the Journal of Vascular and Interventional Radiology.
An upcoming healthcare technology conference is forging ahead with its regularly scheduled program, despite the risk of coronavirus and other healthcare conferences postponing their events, according to an update.
